Leadership Overview
Versiti has 10 executives leading key functions including strategy, information technology, finance, marketing, and human resources.
Driven by a commitment to advancing blood health, Versiti provides innovative solutions in transfusion medicine, transplantation, and blood-related diseases, enhancing patient outcomes and healthcare system efficiencies nationwide.
Driven by a commitment to advancing blood health, Versiti provides innovative solutions in transfusion medicine, transplantation, and blood-related diseases, enhancing patient outcomes and healthcare system efficiencies nationwide.
Leadership Roles at Versiti
Byron Buhner - President & Chief Executive Officer
Byron Buhner, the President & Chief Executive Officer at Versiti, directs the organization's strategic vision and operational execution. Buhner's leadership ensures Versiti fulfills its mission to improve patient health and support healthcare partners through innovative blood health solutions. This involves guiding initiatives in transfusion medicine, transplantation, and the management of blood-related diseases. The President & Chief Executive Officer oversees the integration of value-added services across the national network, driving advancements that lead to improved patient outcomes and cost efficiencies for healthcare systems. Byron Buhner's focus remains on fostering a culture of innovation and excellence, positioning Versiti at the forefront of blood health advancements and ensuring sustained growth and impact across the United States.
Dennis Mestrich - President & Chief Executive Officer
Dennis Mestrich, the President & Chief Executive Officer at Versiti, spearheads the company's overarching strategy and operational framework. Mestrich's role centers on advancing Versiti's mission to enhance patient health and empower healthcare partners through pioneering blood health innovations. This leadership encompasses driving progress in transfusion medicine, transplantation services, and addressing complex blood-related diseases. The President & Chief Executive Officer is responsible for orchestrating national initiatives that deliver value-added solutions, ultimately improving patient care and generating economic efficiencies for healthcare providers. Dennis Mestrich's commitment is to solidify Versiti's position as a national leader, ensuring continuous improvement in service delivery and expanding access to critical care across the nation.
Christopher Miskel - President & Chief Executive Officer
Christopher Miskel, the President & Chief Executive Officer at Versiti, commands the strategic direction and comprehensive operational management of the organization. Miskel's leadership is pivotal in advancing Versiti's core mission: enhancing patient well-being and ensuring the success of its healthcare collaborators through cutting-edge blood health solutions. This involves directing efforts in transfusion medicine, transplantation, and the treatment of blood disorders. The President & Chief Executive Officer guides the implementation of value-added services nationwide, contributing to superior patient outcomes and significant cost savings for healthcare infrastructures. Christopher Miskel's dedication is to foster a dynamic environment that champions innovation, expands healthcare access, and solidifies Versiti's leadership in the blood health sector across the United States.
Terri Ainsworth - Chief Financial Officer
Terri Ainsworth, the Chief Financial Officer at Versiti, directs the organization's financial strategy and fiscal operations. Ainsworth ensures Versiti maintains robust financial health to support its mission of advancing patient well-being and empowering healthcare partners through innovative blood health solutions. This involves meticulous management of budgets, financial planning, and resource allocation across transfusion medicine, transplantation, and blood-related disease programs. The Chief Financial Officer oversees all financial reporting, compliance, and investment strategies, driving economic efficiencies nationwide. Terri Ainsworth's leadership is critical in optimizing financial performance, ensuring the sustainability of Versiti's operations, and supporting the expansion of access to critical healthcare services across the United States.
Anthony Watkins - Executive Vice President & Chief Financial Officer
Anthony Watkins, the Executive Vice President & Chief Financial Officer at Versiti, leads the financial architecture and operational fiscal management for the organization. Watkins ensures Versiti's financial stability and strategic resource deployment to advance its mission of enhancing patient health and supporting healthcare collaborators with pioneering blood health innovations. This encompasses rigorous oversight of financial planning, capital allocation, and risk management across transfusion medicine, transplantation, and blood disorder initiatives. The Executive Vice President & Chief Financial Officer drives initiatives for financial optimization, contributing to improved patient outcomes and cost efficiencies for healthcare systems nationally. Anthony Watkins's expertise is vital in sustaining Versiti's growth and expanding its reach in critical healthcare services.
Sarah Kenyon - Executive Assistant To Chief Financial Officer and Chief Human Resources Officer
Sarah Kenyon, the Executive Assistant To Chief Financial Officer and Chief Human Resources Officer at Versiti, provides critical administrative and operational support to key executive functions. Kenyon facilitates the seamless execution of financial strategies and human resources initiatives, directly contributing to Versiti's mission of improving patient health and supporting its healthcare partners. This involves managing complex schedules, coordinating high-level meetings, and ensuring efficient communication flows between the Chief Financial Officer, Chief Human Resources Officer, and their respective departments. The Executive Assistant To Chief Financial Officer and Chief Human Resources Officer plays a vital role in maintaining organizational efficiency and supporting the strategic objectives that drive Versiti's advancements in transfusion medicine and transplantation services nationwide.
Derek Tyus - Executive Vice President & Chief Financial Officer
Derek Tyus, the Executive Vice President & Chief Financial Officer at Versiti, oversees the financial strategy and operational fiscal management critical to the organization's mission. Tyus ensures Versiti maintains robust financial health and optimizes resource allocation to support advancements in patient care and healthcare partner success through pioneering blood health solutions. This includes rigorous management of financial planning, budgeting, and investment strategies across transfusion medicine, transplantation, and blood disorder programs. The Executive Vice President & Chief Financial Officer drives initiatives focused on financial performance and efficiency, contributing to improved patient outcomes and cost-effectiveness for healthcare systems nationwide. Derek Tyus's financial acumen is key to Versiti's sustained growth and expanded national reach.
Rodeina Davis - Chief Information Officer
Rodeina Davis, the Chief Information Officer at Versiti, architects and executes the organization's comprehensive technology strategy. Davis ensures that Versiti's information systems robustly support its mission of improving patient health and enabling healthcare partner success through advanced blood health solutions. This involves overseeing the integration and optimization of technology across transfusion medicine, transplantation, and blood-related disease management. The Chief Information Officer drives digital transformation initiatives, enhancing operational efficiency and data security nationwide. Rodeina Davis's focus is on leveraging technology to expand access to care, improve patient outcomes, and provide cost-effective solutions, positioning Versiti at the forefront of technological innovation within the health services sector.
Chrissy Schroeder - Executive Vice President & Chief Marketing Officer
Chrissy Schroeder, the Executive Vice President & Chief Marketing Officer at Versiti, directs the organization's comprehensive marketing and brand strategy. Schroeder ensures Versiti's value proposition is effectively communicated to patients, healthcare partners, and the broader community, reinforcing its mission to improve blood health. This involves leading initiatives in market analysis, brand development, and strategic communications across all service lines, including transfusion medicine and transplantation. The Executive Vice President & Chief Marketing Officer oversees campaigns designed to enhance patient access to care and highlight Versiti's role in driving healthcare efficiencies nationwide. Chrissy Schroeder's focus is on building strong brand recognition and driving engagement that supports Versiti's leadership in blood health innovation.
James Weidner - Executive Vice President & Chief Human Resources Officer
James Weidner, the Executive Vice President & Chief Human Resources Officer at Versiti, leads the strategic development and execution of all human capital initiatives. Weidner ensures Versiti cultivates a high-performing workforce dedicated to its mission of advancing patient health and supporting healthcare partners through innovative blood health solutions. This involves overseeing talent acquisition, employee development, compensation, and organizational culture across all national operations. The Executive Vice President & Chief Human Resources Officer drives programs that foster employee engagement and align human resources strategies with Versiti's goals in transfusion medicine, transplantation, and blood-related disease management. James Weidner's leadership is essential for building a robust and motivated team that underpins Versiti's success and expanded healthcare access.
Explore Leadership Teams in Blood & Organ Banks
CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies.
Company Leadership GN

HM
CN
Vitalant is a national community blood service provider, supplying comprehensive transfusion medicine services for hospitals and health care partners for patients in need. Vitalant inspires local communities to serve the needs of others and transform lives through the selfless act of donating blood.
Company Leadership MF

KC

Serum Institute of India Pvt. Ltd., founded in 1966 and headquartered in Pune, India, is a manufacturer of immunobiological drugs including vaccines in India.
Company Leadership PD
MC
Novavax, Inc. is a biotechnology company incorporated in 1987 and headquartered in Gaithersburg, Maryland, focused on discovering, developing, and commercializing vaccines to protect against serious infectious diseases. The company's proprietary technology platform combines a recombinant protein approach, nanoparticle technology, and a patented adjuvant to enhance immune response. Novavax's pipeline spans vaccine candidates targeting infectious diseases including COVID-19, influenza, respiratory syncytial virus, malaria, shingles, and other pathogens, with ongoing exploration of its adjuvant platform in oncology. The company maintains a strategic partnership with Sanofi for COVID-19 vaccine commercialization and has established licensing and collaboration agreements with major global pharmaceutical companies. Novavax trades on the NASDAQ under the ticker symbol NVAX.
Company Leadership
RM

LF